- Home
- JGH vs TKNO Comparison
JGH vs TKNO Comparison
Compare JGH & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JGH
- TKNO
- Stock Information
- Founded
- JGH 2014
- TKNO 1996
- Country
- JGH United States
- TKNO United States
- Employees
- JGH N/A
- TKNO N/A
- Industry
- JGH Investment Managers
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- JGH Finance
- TKNO Health Care
- Exchange
- JGH Nasdaq
- TKNO Nasdaq
- Market Cap
- JGH 304.1M
- TKNO 244.7M
- IPO Year
- JGH N/A
- TKNO 2021
- Fundamental
- Price
- JGH $13.05
- TKNO $5.91
- Analyst Decision
- JGH
- TKNO Buy
- Analyst Count
- JGH 0
- TKNO 2
- Target Price
- JGH N/A
- TKNO $5.00
- AVG Volume (30 Days)
- JGH 73.9K
- TKNO 269.2K
- Earning Date
- JGH 01-01-0001
- TKNO 11-07-2024
- Dividend Yield
- JGH 9.85%
- TKNO N/A
- EPS Growth
- JGH N/A
- TKNO N/A
- EPS
- JGH N/A
- TKNO N/A
- Revenue
- JGH N/A
- TKNO $36,347,000.00
- Revenue This Year
- JGH N/A
- TKNO $3.56
- Revenue Next Year
- JGH N/A
- TKNO $13.31
- P/E Ratio
- JGH N/A
- TKNO N/A
- Revenue Growth
- JGH N/A
- TKNO N/A
- 52 Week Low
- JGH $10.36
- TKNO $1.16
- 52 Week High
- JGH $12.85
- TKNO $7.92
- Technical
- Relative Strength Index (RSI)
- JGH 51.34
- TKNO 44.25
- Support Level
- JGH $13.08
- TKNO $6.15
- Resistance Level
- JGH $13.33
- TKNO $7.92
- Average True Range (ATR)
- JGH 0.11
- TKNO 0.69
- MACD
- JGH 0.03
- TKNO -0.17
- Stochastic Oscillator
- JGH 51.72
- TKNO 0.50
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.